In The News
Hytera can’t dodge finding it committed ‘industrial theft’ of Motorola’s source code
Judge approves $31.5M settlement in junior doctors class action
Barrister who accepted briefs for appearances on same day referred to watchdog
Hall & Wilcox brings on Moray & Agnew public law specialist
Slashing funder’s stolen wages cut could deter public interest cases, court told
Law firm files first class action over Google’s ad tech dominance
Landmark $50M settlement over Meta’s Cambridge Analytica scandal
Qantas to pay $120M to settle ground crew outsourcing case
Westpac shouldn’t mediate employee suit with ‘one hand behind back’: court
Active Super says ASIC penalty would fall on ‘poor old members’
Please login to bookmarkClose

The Full Federal Court has shot down Reckitt Benckiser’s appeal of a ruling that it misled consumers with claims that its Nurofen is a more effective pain killer than rival GlaxoSmithKline’s Panadol.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au